Skip to main content
Genmab A/S (CPH:GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
1,438.50
+35.50 (2.53%)
Jun 4, 2025, 4:59 PM CET

Genmab Revenue

Genmab had revenue of $715.00M USD in the quarter ending March 31, 2025, with 18.57% growth. This brings the company's revenue in the last twelve months to $3.23B, up 25.43% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.

Revenue (ttm)
$3.23B
Revenue Growth
+25.43%
P/S Ratio
3.97
Revenue / Employee
$1.20M
Employees
2,682
Market Cap
88.60B DKK

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.99B545.24M22.32%
Dec 31, 20232.44B358.99M17.23%
Dec 31, 20222.08B796.62M61.88%
Dec 31, 20211.29B-374.23M-22.52%
Dec 31, 20201.66B855.79M106.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novo Nordisk 303.14B
Coloplast 27.79B
Demant 22.42B
ALK-Abelló 5.71B
H. Lundbeck 22.95B
Zealand Pharma 55.69M
Ambu A/S 5.83B
GN Store Nord 17.67B
Revenue Rankings

Genmab News

More News